The company has been improving manufacturing processes and fixed costs over four years and could expect to see 8 to 10 percent free cash flow yield, according to the report.
Zimmer has also been investing in emerging markets, such as China and India.
More Articles on Supply Chain:
American Spine Expands to Gettysburg
Miami Project to Cure Paralysis Successfully Transplants Human Cells for Spinal Cord Injury
Outlook for Spinal Non-Fusion Technology Trends: Q&A with Joe Ross of LDR
